Resources from the same session
1914MO - The clinico-radiological outcome of desmoid type-fibromatosis after discontinuing the sorafenib treatment in responders: Single-arm phase II clinical trial
Presenter: Sameer Rastogi
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1915MO - Fear, anxiety and depression in gastrointestinal stromal tumor (GIST) patients in the Netherlands: Data from a cross-sectional multicenter study
Presenter: Deborah van de Wal
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
Invited Discussant 1914MO and 1915MO
Presenter: Piotr Rutkowski
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast
1916MO - A first-in-human phase I trial of NB003, a potent and selective KIT/PDGFRa inhibitor, in patients with advanced gastrointestinal stromal tumors (GIST)
Presenter: Ping Chi
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1917MO - CHAPTER-GIST-101: A phase I study of pimitespib combined with imatinib in patients with imatinib-refractory gastrointestinal stromal tumor
Presenter: Yoichi Naito
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1918MO - Circulating tumor DNA in relation to tumor volume in gastro-intestinal stromal tumors
Presenter: Roos Bleckman
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
Invited Discussant 1916MO, 1917MO and 1918MO
Presenter: Kjetil Boye
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast
1919MO - Efficacy and safety of botensilimab (BOT) plus balstilimab (BAL) in patients (pts) with refractory metastatic sarcoma
Presenter: Breelyn Wilky
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1920MO - Regomune: A phase II study of regorafenib + avelumab in solid tumors - Results of the advanced or metastatic gastrointestinal stromal tumors (mGIST) cohort
Presenter: Sophie Cousin
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1921MO - Patterns of care, outcome and molecular landscape of PATZ1-rearranged sarcomas identifies two prognostic profiles: A cohort study from the French Sarcoma Group (FSG)
Presenter: Helene Vanacker
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast